| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Basics of the virology of HIV-1 and its replication
|
Sierra, Saleta
|
|
2005
|
34 |
4 |
p. 233-244
12 p.
|
article
|
| 2 |
CCR2-64I and CXCL12 3′A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy
|
Passam, Andrew M.
|
|
2005
|
34 |
4 |
p. 302-309
8 p.
|
article
|
| 3 |
Clonal analysis of HIV-1 variants in proviral DNA during treatment interruption in patients with multiple therapy failures
|
Boucher, Sébastien
|
|
2005
|
34 |
4 |
p. 288-294
7 p.
|
article
|
| 4 |
Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates
|
Tsongalis, G.J.
|
|
2005
|
34 |
4 |
p. 268-271
4 p.
|
article
|
| 5 |
Comprehensive comparison of the VERSANT® HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR® 1.5 assays on 1000 clinical specimens
|
Galli, Rick
|
|
2005
|
34 |
4 |
p. 245-252
8 p.
|
article
|
| 6 |
Detection and quantification of proviral HIV-1 184M/V in circulating CD4+ T cells of patients on HAART with a viremia less than 1000 copies/ml
|
Mohey, Rajesh
|
|
2005
|
34 |
4 |
p. 257-267
11 p.
|
article
|
| 7 |
Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population
|
Apostolakis, S.
|
|
2005
|
34 |
4 |
p. 310-314
5 p.
|
article
|
| 8 |
Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy
|
Poveda, Eva
|
|
2005
|
34 |
4 |
p. 295-301
7 p.
|
article
|
| 9 |
ESCV Meeting Calender
|
|
|
2005
|
34 |
4 |
p. IV-
1 p.
|
article
|
| 10 |
ESCV Membership
|
|
|
2005
|
34 |
4 |
p. I-II
nvt p.
|
article
|
| 11 |
Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy
|
Balduin, Melanie
|
|
2005
|
34 |
4 |
p. 277-287
11 p.
|
article
|
| 12 |
HBV genotype G—an odd genotype of unknown origin
|
Lindh, Magnus
|
|
2005
|
34 |
4 |
p. 315-316
2 p.
|
article
|
| 13 |
HIV-1 drug resistance in Thailand: Before and after National Access to Antiretroviral Program
|
Sutthent, Ruengpung
|
|
2005
|
34 |
4 |
p. 272-276
5 p.
|
article
|
| 14 |
IFC
|
|
|
2005
|
34 |
4 |
p. CO2-
1 p.
|
article
|
| 15 |
[No title]
|
Myrmel, H.
|
|
2005
|
34 |
4 |
p. 317-
1 p.
|
article
|
| 16 |
PASCV Membership
|
|
|
2005
|
34 |
4 |
p. III-
1 p.
|
article
|
| 17 |
TaqMan RT-PCR and VERSANT® HIV-1 RNA 3.0 (bDNA) assay
|
Israel-Ballard, Kiersten
|
|
2005
|
34 |
4 |
p. 253-256
4 p.
|
article
|
Journal description